Fig. 2From: Immunological analysis of phase II glioblastoma dendritic cell vaccine (Audencel) trial: immune system characteristics influence outcome and Audencel up-regulates Th1-related immunovariablesPre-Audencel blood CD8+ count. a Example of “low” and “high” CD8+ count. b CD8+ count correlated with survival (p = 0.005, n = 32). c Significant survival curve separation (p = 0.018, n = 32)Back to article page